Abstract: Primary localized cutaneous amyloidosis is a skin-limited amyloidosis that does not involve internal organs. It is clinically subclassified into 3 general categories and some rare variants. However, there is considerable overlap within the classification. Though there are a variety of therapeutic measures, the treatment is often unsatisfactory, particularly when the disease is severe and extensive. We describe a rare case of primary localized cutaneous amyloidosis with lichen and poikiloderma-like lesions that showed an excellent response to systemic acitretin.
INTRODUCTION
Primary localized cutaneous amyloidosis (PLCA) is characterized by the limited deposition of amyloid in the skin, without deposition in any internal organs. 1 There are a variety of clinical phenotypes and treatment is often difficult, particularly when the disease is severe and extensive. In this study, we describe a rare case of PLCA with lichen and poikiloderma-like lesions and an excellent response to systemic acitretin.
CASE REPORT
A 22-year-old woman had endured multiple, mildly pruritic, red-purple skin lesions on her face, external ear, neck and upper back for twenty years ( Figure 1 ). [1] [2] [3] The eruptions initially developed as papules on her face and spread gradually to the other locations.
Some lesions on the forehead and bilateral parts of the malar region and cheeks (is this a repetition of the same idea?) coalesced into plaques, while others on the upper back partly subsided spon- (the most common type); and nodular amyloid (the rarest). Second, they can regulate levels of several heat-shock proteins that may prevent aberrant folding of keratin into amyloids. Third, retinoids can also reduce apolipoprotein E secretion, a protein found together with amyloids that is considered crucial in promoting its formation. 7 As Gal-7 is an important amyloid precursor protein in PLCA, further studies are necessary to investigate the association between Gal-7 and retinoids.q 
